- Home
- NKTR vs MED Comparison
NKTR vs MED Comparison
Compare NKTR & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- MED
- Stock Information
- Founded
- NKTR 1990
- MED 1980
- Country
- NKTR United States
- MED United States
- Employees
- NKTR N/A
- MED N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- MED Packaged Foods
- Sector
- NKTR Health Care
- MED Consumer Staples
- Exchange
- NKTR Nasdaq
- MED Nasdaq
- Market Cap
- NKTR 160.4M
- MED 139.0M
- IPO Year
- NKTR 1994
- MED N/A
- Fundamental
- Price
- NKTR $0.64
- MED $11.92
- Analyst Decision
- NKTR Strong Buy
- MED Hold
- Analyst Count
- NKTR 6
- MED 1
- Target Price
- NKTR $4.92
- MED $16.50
- AVG Volume (30 Days)
- NKTR 2.8M
- MED 253.6K
- Earning Date
- NKTR 05-08-2025
- MED 04-28-2025
- Dividend Yield
- NKTR N/A
- MED N/A
- EPS Growth
- NKTR N/A
- MED N/A
- EPS
- NKTR N/A
- MED 0.19
- Revenue
- NKTR $98,427,000.00
- MED $602,463,000.00
- Revenue This Year
- NKTR N/A
- MED N/A
- Revenue Next Year
- NKTR N/A
- MED N/A
- P/E Ratio
- NKTR N/A
- MED $62.74
- Revenue Growth
- NKTR 9.21
- MED N/A
- 52 Week Low
- NKTR $0.43
- MED $11.88
- 52 Week High
- NKTR $1.93
- MED $36.30
- Technical
- Relative Strength Index (RSI)
- NKTR 45.85
- MED 32.66
- Support Level
- NKTR $0.43
- MED $11.88
- Resistance Level
- NKTR $0.68
- MED $13.54
- Average True Range (ATR)
- NKTR 0.08
- MED 0.64
- MACD
- NKTR 0.01
- MED -0.09
- Stochastic Oscillator
- NKTR 72.41
- MED 2.03
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.